Pfizer/Valneva Lyme disease vaccine persists 6 months on
On 1st December 2022 Pfizer and Valneva reported antibody persistence data 6 months after the completion of a vaccination schedule with their Lyme disease vaccine candidate, VLA15. This was reported in both children and adults, the first time that antibody resistance...
Africa CDC gets mpox vaccine donation from Republic of Korea
During a bilateral meeting between Dr Ahmed Ogwell Ouma, Acting Director General of Africa CDC, and Korea Disease Control and Prevention Agency (KDCA) Commissioner PECK Kyong Ran it was announced that the KDCA will donate a batch of the mpox vaccine to Africa. The...
COVID-19 vaccine for infants: antibodies persist a year on
During the COVID-19 pandemic immunisation of infants has been a highly contentious and confusing issue. From initial advice
MOST POPULAR THIS MONTH
HDT Bio and UTMB partner against CCHFV and NiV
In November 2022 HDT Bio Corp. and the University of Texas Medical Branch (UTMB) revealed that they had been awarded a project agreement worth up to $87.4 million. The US Department of Defence’s (DOD) Joint Programme Executive Office for Chemical, Biological,...
Marking World AIDS Day 2022: “equalise” theme
1st December 2022 is World AIDS Day, with global communities observing it under the theme “equalise”. This year, the WHO is calling on “leaders and citizens” to identify and address the inequalities that challenge progress in “attaining the global goal to end AIDS by...
US announces further Global Health Security Partnerships
In November 2022 the White House issued a statement indicating the intention of the Biden-Harris Administration to continue to “prioritise global health security” as part of wider efforts in “national biodefence”. Highlighting ongoing outbreaks alongside the continued...
PharmaJet announces grant from NIH for HPV
In November 2022 PharmaJet announced that it had received an NIH grant of $800,000 towards their Phase II investigation of the immunogenicity of intradermal administration of a human papillomavirus (HPV) vaccine. Using PharmaJet’s Tropis intradermal (ID) needle-free...
WHO approval for Republic of Korea regulator
The WHO announced in November that the Ministry of Food and Drug Safety (MFDS), Republic of Korea, achieved maturity level 4 (ML4) in its ranking of regulatory authorities for medical products. This is the highest level. Out of 33 countries assessed, only the Republic...
CEPI collaboration with UQ on Disease X platform
In November 2022 CEPI announced an investment of U$5.7 million towards the development of a second-generation molecular clamp vaccine platform at the University of Queensland (UQ). This platform will be aimed at “combatting the next Disease X”. The funds will...
WHO: Monkeypox virus gets rebranded as Mpox
The WHO announced in November 2022 that, after “consultations with global experts”, it will begin using a preferred term “mpox” for monkeypox. While the word monkeypox is “phased out” both terms will be used simultaneously for one year. This move is made in attempts...
Exclusive interview with Dr Ariel Weinberger
With the World Vaccine and Immunotherapy Congress kicking off in San Diego today we are delighted to share another exclusive interview with the community. We were lucky to hear from Dr Ariel Weinberger, founder and CEO of Autonomous Therapeutics since 2017. Autonomous...
LATEST
UK applies Vaccine Taskforce model to health problems
The UK government announced in November 2022 that it would be introducing a “Vaccine Taskforce style approach” to some of the biggest health challenges
Group A strep kills child in England with another recovering
In November 2022 it was reported that a child, around the age of 6, had died after catching an infection caused by the group A streptococcus bacteria.
Universal flu vaccine hopes renewed in new data
A study published in Science in November 2022 has given experts in the UK reason to predict that a universal flu vaccine might be available sooner
WHO declares measles a dangerous “growing threat”
The WHO announced that almost 40 million children were “dangerously susceptible” to the “growing threat” of measles following a decline in vaccination
Relief from UTIs offered by sublingual vaccine
A research paper published in Science Advances suggests the possibility of UTI prevention through a sublingual vaccine. The paper details the success
Vaccines: the missing piece in the dementia puzzle?
Dementia is described by the NHS as a syndrome associated with an “ongoing decline of brain functioning”. This may manifest in an impaired ability to remember,
VIDEOS
World Vaccine Congress Europe 2022: meet our partners!
At the World Vaccine Congress we are counting down the days to our Congress in Europe, 2022. If you haven't yet bought your tickets there is still time! With under a week to go we are pleased to share a list of supporting partners. You might see some familiar names......
World Vaccine Congress Europe 2022: Chats with Chaudhrey
With just over a week to go until the World Vaccine Congress in Europe 2022, our editor Charlotte was asked to speak to Rizwan Chaudhrey for his YouTube series, #ChatsWithChaudrey. To hear their conversation watch the video below or head to his YouTube channel! If you...
World Vaccine Congress Europe 2022: meet our exhibitors!
We hope you are looking forward to our World Vaccine Congress in Barcelona, 2022; we certainly are! We are pleased to tease some of the amazing exhibitors who will be in attendance in this short video. If you are interested in learning more about exhibiting then...
World Vaccine Congress Europe 2022: meet our sponsors!
Here at the World Vaccine Congress we are looking forward to meeting everyone at our Congress in Barcelona, October 2022. To introduce some the sponsors we have
World Vaccine Congress Europe 2022 trailer!
Check out the trailer for our World Vaccine Congress in Europe 2022!
World Vaccine Congress 2022 Washington reel!
Check out this video from our World Vaccine Congress 2022!
THERAPEUTIC
Exclusive interview with Dr Stephen Johnston
As we gear up towards the World Vaccine and Immunotherapy Congress in San Diego later this month we have been meeting a few of our speakers
AELIX Therapeutics study in Nature meets endpoints
In November 2022 the results of the AELIX-002 trial were published in Nature by collaborators from Aelix Therapeutics and Gilead Sciences.
Exclusive interview with Dr Andrew Vaillant
As we look forward to future events, a conversation with Dr Andrew Vaillant links our event in Barcelona to the World Vaccine and Immunotherapy Congress
Glioblastoma vaccine offers longer life to patients
In a study, researchers collaborated to demonstrate “clinically meaningful and statistically significant extension of survival” for patients
Fentanyl vaccine shows therapeutic promise in rats
A study by researchers led by the University of Houston demonstrates potential to eliminate the high caused by the synthetic opioid fentanyl.
TECHNOLOGY
HDT Bio and UTMB partner against CCHFV and NiV
In November 2022 HDT Bio Corp. and the University of Texas Medical Branch (UTMB) revealed that they had been awarded a project agreement worth up to $87.4 m
PharmaJet announces grant from NIH for HPV
PharmaJet announced that it had received an NIH grant towards their Phase II investigation of the immunogenicity of intradermal administration of HPV vaccine.
CEPI collaboration with UQ on Disease X platform
In November 2022 CEPI announced an investment of U$5.7 million towards the development of a second-generation molecular clamp vaccine platform at the UQ
Exclusive interview with Dr Ariel Weinberger
With the World Vaccine and Immunotherapy Congress just days away we are delighted to share another exclusive interview with the community
Exclusive interview with Dr Erin Spiegel
While we were in Barcelona this year for the World Vaccine Congress 2022 we had the exciting opportunity to meet Dr Erin Spiegel.
INFECTION
COVID-19 vaccine for infants: antibodies persist a year on
During the COVID-19 pandemic immunisation of infants has been a highly contentious and confusing issue. From initial advice
Pfizer/Valneva Lyme disease vaccine persists 6 months on
On 1st December 2022 Pfizer and Valneva reported antibody persistence data 6 months after vaccination with their Lyme disease vaccine candidate, VLA15.
Africa CDC gets mpox vaccine donation from Republic of Korea
During a meeting between Acting Director General of Africa CDC, and KDCA Commissioner it was announced that the KDCA will donate a batch of the mpox vaccine
Marking World AIDS Day 2022: “equalise” theme
1st December 2022 is World AIDS Day, with global communities observing it under the theme “equalise”. This year, the WHO is calling on “leaders and citizens
WHO: Monkeypox virus gets rebranded as Mpox
The WHO announced in November 2022 that, after “consultations with global experts”, it will begin using a preferred term “mpox” for monkeypox.
GLOBAL HEALTH
US announces further Global Health Security Partnerships
White House issued a statement indicating the intention of the Biden-Harris Administration to continue to “prioritise global health security”
WHO approval for Republic of Korea regulator
The WHO announced in November that the Ministry of Food and Drug Safety (MFDS), Republic of Korea, achieved maturity level 4 (ML4) in its ranking
UK applies Vaccine Taskforce model to health problems
The UK government announced in November 2022 that it would be introducing a “Vaccine Taskforce style approach” to some of the biggest health challenges
WHO declares measles a dangerous “growing threat”
The WHO announced that almost 40 million children were “dangerously susceptible” to the “growing threat” of measles following a decline in vaccination
Vaccines: the missing piece in the dementia puzzle?
Dementia is described by the NHS as a syndrome associated with an “ongoing decline of brain functioning”. This may manifest in an impaired ability to remember,
